Evaluation of the effect of N-acetyl-glucosamine administration on biomarkers for cartilage metabolism in healthy individuals: a randomized double-blind placebo-controlled clinical study
Journal Title: Functional Foods in Health and Disease - Year 2017, Vol 7, Issue 8
Abstract
Background: A randomized double-blind placebo-controlled clinical study was conducted to evaluate the chondroprotective action of N-acetyl-glucosamine (GlcNAc) supplement on healthy individuals without arthritis. Methods: Healthy subjects (n=120, 54.3 ± 8.1 years (mean ± SD)) without arthritis were randomly assigned to receive 500 mg GlcNAc (n=60, GlcNAc group) or a placebo (n=60, placebo group) once a day for 16 weeks, and cartilage metabolism was evaluated by analyzing type II collagen degradation (C2C) and type II collagen synthesis (PIICP) markers, and the ratio of type II collagen degradation to type II collagen synthesis (C2C/PIICP). Results: Among 120 eligible subjects, 114 subjects completed the study. First, all the subjects with a body mass index of ≥25 kg/m2 and Kellgren and Lawrence grade of ≥1 were analyzed. However, the changes in the C2C and PIICP levels and the C2C/PIICP ratios from the baseline were not significantly different between the placebo and GlcNAc groups during 16 weeks and 8 weeks after the intervention. Next, to make the effect of GlcNAc even clearer, the subjects with body mass index of <25 kg/m2 and Kellgren and Lawrence grade of 0 were analyzed. The changes in the C2C levels from the baseline were significantly decreased in the GlcNAc group compared with the placebo group at 8 and 12 weeks during the intervention. In contrast, the changes in the PIICP levels from the baseline levels were almost constant during and after the intervention in both groups. Based on these findings, the changes in the C2C/CIICP ratios from the baseline slightly decreased in the GlcNAc group compared to the placebo group at 8 and 12 weeks during the intervention. Furthermore, no test supplement-related adverse events were observed during and after the intervention. Conclusions: These observations suggest that oral administration of GlcNAc at a dose of 500 mg/day exerts a chondroprotective effect in subjects without arthritis. This effect was achieved by improving cartilage metabolism (reducing type II collagen degradation), without causing apparent adverse effects.
Authors and Affiliations
Akihito Tomonaga, Mitsuhiko Fukagawa, Asahi Suzuki, Mihoko Kurokawa, Isao Nagaoka
Keywords
Related Articles
- EP ID EP435571
- DOI 10.31989/ffhd.v7i8.366
- Views 125
- Downloads 0
LC-MS determination of L-DOPA concentration in the leaf and flower tissues of six faba bean (Vicia faba L.) lines with common and rare flower colors
Background: Parkinson’s disease (PD) is the second most common neurodegenerative disorder characterized by the loss of muscle control, which causes trembling of the limbs and head as well as impaired balance. L-DOPA (L-3...
The effects of bioactive compounds on Alzheimer’s disease and mild cognitive impairment
Prevalence rates of Alzheimer’s disease are increasing in countries around world, and identifying effective treatments to manage cognitive impairment and neurodegeneration has become a global health priority. Decades of...
Water-soluble low-molecular-weight b-(1, 3–1, 6) D-Glucan inhibit cedar pollinosis
Background: The incidences of allergenic diseases such as allergenic rhinitis, atopic dermatitis, asthma, and food allergies have increased in several countries. Mast cells have critical roles in various biological proce...
Anti-atherosclerotic effects of konjac
Definition: The Konjac plant comes from the genus Amorphophallus. Japanese food uses Konjac cake. Konjac contains almost no calories and a great amount of dietary fiber. Here, we reviewed possible anti-atherosclerotic ef...
A randomized, double-blind, placebo-controlled study evaluating the effects of quercetin-rich onion on cognitive function in elderly subjects
Background: Quercetin, a phenolic compound, has various functional effects, including anti-oxidant, anti-dyslipidaemic and anti-dysglycemic activities, and beneficial effects on cognitive function. Methods: We evaluated...